financetom
MGPI
financetom
/
Consumer Staples
/
MGPI
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
MGP Ingredients, Inc.MGPI
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

MGP Ingredients, Inc., together with its subsidiaries, produces and supplies distilled spirits, branded spirits, and food ingredients in the United States and internationally.

It operates through three segments: Distillery Solutions; Branded Spirits; and Ingredient Solutions. The Distillery Solutions segment provides food grade alcohol for beverage applications that include bourbon and rye, whiskeys, as well as grain neutral spirits, include vodka and gin; and food-grade industrial alcohol, which is used as an ingredient in foods, personal care products, cleaning solutions, pharmaceuticals, and various other products.

This segment also provides fuel-grade alcohol for blending with gasoline; distillers feed and related co-products, such as distillers feed and corn oil; and warehouse services, include barrel put away, storage, and retrieval, as well as blending services.

The Branded Spirits segment provides ultra-premium, super premium, premium, mid, and value branded distilled spirits.

The Ingredient Solutions segment provides specialty wheat starches for food applications under the Fibersym, Resistant Starch series, and FiberRite RW Resistant Starch names; specialty wheat proteins for food applications under the Arise and Proterra names; gluten-free textured pea proteins; commodity wheat starch for food and non-food applications; and commodity wheat proteins.

The company sells its products directly or through distributors to manufacturers and processors of finished packaged goods or to bakeries.

MGP Ingredients, Inc. was founded in 1941 and is headquartered in Atchison, Kansas.

Latest News >
Update: Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group
Update: Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group
Apr 3, 2024
09:02 AM EDT, 04/03/2024 (MT Newswires) -- (Updates to add Cloud Software Group's comment in the last paragraph.) Revvity ( RVTY ) said Tuesday that the Massachusetts Superior Court has issued a preliminary injunction compelling Cloud Software Group to comply with its obligations under its strategic partner agreements, including an order to cease all marketing, selling and support activities in...
First Solar Insider Sold Shares Worth $407,328, According to a Recent SEC Filing
First Solar Insider Sold Shares Worth $407,328, According to a Recent SEC Filing
Apr 3, 2024
09:03 AM EDT, 04/03/2024 (MT Newswires) -- Georges Antoun, Chief Commercial Officer, on April 01, 2024, sold 2,400 shares in First Solar ( FSLR ) for $407,328. Following the Form 4 filing with the SEC, Antoun has control over a total of 39,812 shares of the company, with 39,812 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1274494/000112760224011972/xslF345X03/form4.xml Price: 166.08, Change: -1.09, Percent...
JPMorgan Chase launches digital media business
JPMorgan Chase launches digital media business
Apr 3, 2024
(Reuters) - JPMorgan Chase ( JPM ) on Wednesday launched a new digital media business that would allow advertisers to target the Wall Street bank's 80 million customers based on their spending data. The new platform called Chase Media Solutions will combine the scale of a retail media network with Chase-owned transaction data that will help brands to precisely target...
Bristol-Myers' Reblozyl Approved in EU as First-Line Treatment of Transfusion-Dependent Anemia
Bristol-Myers' Reblozyl Approved in EU as First-Line Treatment of Transfusion-Dependent Anemia
Apr 3, 2024
09:03 AM EDT, 04/03/2024 (MT Newswires) -- Bristol-Myers Squibb ( BMY ) said late Tuesday that Reblozyl has received its fourth authorized indication in the European Union, with its approval as a first-line treatment of transfusion-dependent anemia in adults with lower risk myelodysplastic syndromes. The approval by the European Commission covers all EU member countries, the company said. The approval...
Copyright 2023-2025 - www.financetom.com All Rights Reserved